Vaginal Microbiome Distinction in Women with HPV+, Cervical Intraepithelial Neoplasia, and Cervical Cancer, a Retrospective Study

Overview

Journal Front Cell Infect Microbiol

Date 2025 Feb 3

PMID 39897478

Authors

Yuanyue Li

Xiaomei Wu

Affiliations

Soon will be listed here.

Abstract

Introduction: The vaginal microbiota is a complex and dynamic micro-ecosystem that plays a pivotal role in protecting the host from various pathogens. Previous studies have investigated the diversity of the vaginal microbiome and its association with health outcomes, particularly the development of HPV-related disorders. This study aimed to investigate the correlation between the vaginal microbiota, HPV infection, cervical intraepithelial neoplasias (CINs), and cervical cancers in 69 women.

Methods: DNA was extracted from vaginal samples, followed by HPV genotyping through PCR and sequenced of the16S rRNA gene.

Results: Our results revealed that was the predominant bacterium across all groups, with prevalence rates of 60.2% in women with HPV+, 63.9% in CINI, 97.7% in CINII, 52.0% in CINIII, 36.9% in cervical cancer, and 70.9% in NILM (normal cytology). Additionally, an elevated proportion of Gardnerella was identified as a high-risk bacterium associated with HPV infection, potentially contributing to the progression of cervical lesions. High-risk HPV genotypes, particularly HPV16, 52, and 33, were found to be more prevalent among women with HPV+, CIN, and cervical cancer. We also observed significantly higher alpha diversity in the vaginal microbiome of women with HPV+ and CIN, as indicated by increased Sobs, Shannon, Ace, and Chao indices, compared to the NILM group.

Conclusion: These findings suggest that HPV infection and its associated pathological conditions are closely linked to alterations in the vaginal microbiome. This underscores the need for further research to unravel the intricate relationship between HPV genotype infections and vaginal microbiota, which could pave the way for new diagnostic and therapeutic approaches.

References

Avitabile E, Menotti L, Croatti V, Giordani B, Parolin C, Vitali B . Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections. Int J Mol Sci. 2024; 25(17). PMC: 11395631. DOI: 10.3390/ijms25179168. View

Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H . Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2018; 221(1):9-18.e8. DOI: 10.1016/j.ajog.2018.12.011. View

Anahtar M, Gootenberg D, Mitchell C, Kwon D . Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity. Cell Host Microbe. 2018; 23(2):159-168. DOI: 10.1016/j.chom.2018.01.013. View

Lee J, Lee S, Lee H, Song Y, Lee K, Han M . Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One. 2013; 8(5):e63514. PMC: 3661536. DOI: 10.1371/journal.pone.0063514. View

Tachedjian G, Aldunate M, Bradshaw C, Cone R . The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017; 168(9-10):782-792. DOI: 10.1016/j.resmic.2017.04.001. View

Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P . HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination. Tumori. 2023; 110(2):139-145. DOI: 10.1177/03008916231208344. View

Li N, Franceschi S, Howell-Jones R, Snijders P, Clifford G . Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2010; 128(4):927-35. DOI: 10.1002/ijc.25396. View

Turnbaugh P, Ley R, Hamady M, Fraser-Liggett C, Knight R, Gordon J . The human microbiome project. Nature. 2007; 449(7164):804-10. PMC: 3709439. DOI: 10.1038/nature06244. View

Bzhalava D, Arroyo Muhr L, Lagheden C, Ekstrom J, Forslund O, Dillner J . Deep sequencing extends the diversity of human papillomaviruses in human skin. Sci Rep. 2014; 4:5807. PMC: 4108911. DOI: 10.1038/srep05807. View

10.

Smith S, Ravel J . The vaginal microbiota, host defence and reproductive physiology. J Physiol. 2016; 595(2):451-463. PMC: 5233653. DOI: 10.1113/JP271694. View

11.

Boris S, Barbes C . Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000; 2(5):543-6. DOI: 10.1016/s1286-4579(00)00313-0. View

12.

Baloch Z, Yue L, Yuan T, Feng Y, Tai W, Liu Y . Status of Human Papillomavirus Infection in the Ethnic Population in Yunnan Province, China. Biomed Res Int. 2016; 2015:314815. PMC: 4706867. DOI: 10.1155/2015/314815. View

13.

White J, Nagarajan N, Pop M . Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009; 5(4):e1000352. PMC: 2661018. DOI: 10.1371/journal.pcbi.1000352. View

14.

Aldunate M, Srbinovski D, Hearps A, Latham C, Ramsland P, Gugasyan R . Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6:164. PMC: 4451362. DOI: 10.3389/fphys.2015.00164. View

15.

Gilham C, Sargent A, Kitchener H, Peto J . HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Health Technol Assess. 2019; 23(28):1-44. PMC: 6600121. DOI: 10.3310/hta23280. View

16.

Nunn K, Forney L . Unraveling the Dynamics of the Human Vaginal Microbiome. Yale J Biol Med. 2016; 89(3):331-337. PMC: 5045142. View

17.

Kombe Kombe A, Li B, Zahid A, Mengist H, Bounda G, Zhou Y . Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2021; 8:552028. PMC: 7855977. DOI: 10.3389/fpubh.2020.552028. View

18.

Gheit T . Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology. Front Oncol. 2019; 9:355. PMC: 6517478. DOI: 10.3389/fonc.2019.00355. View

19.

de Sanjose S, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B . Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8. View

20.

Borgogna J, Shardell M, Santori E, Nelson T, Rath J, Glover E . The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. BJOG. 2019; 127(2):182-192. PMC: 6982399. DOI: 10.1111/1471-0528.15981. View